InMode Ltd is a leading global provider of innovative energy-based minimally invasive surgical medical treatment solutions. The company develops and commercializes products using radio frequency energy technology to address face and body contouring medical aesthetics and women's wellness treatments. Its portfolio includes platforms that deliver surgical-grade results under local anesthesia while minimizing risks of scarring downtime pain and complications typically…
InMode Ltd is a leading global provider of innovative energy-based minimally invasive surgical medical treatment solutions. The company develops and commercializes products using radio frequency energy technology to address face and body contouring medical aesthetics and women's wellness treatments. Its portfolio includes platforms that deliver surgical-grade results under local anesthesia while minimizing risks of scarring downtime pain and complications typically associated with traditional surgical procedures.
InMode generates revenue through the sale of its medical aesthetic platforms handpieces applicators and proprietary software to healthcare providers. Revenue is derived from minimally invasive platforms hands-free platforms and non-invasive platforms across geographic markets with the United States representing the principal market. The company also earns revenue from consumables training services and ongoing support programs provided to physicians who use its products for various aesthetic and wellness procedures.
The company operates through the following segments: Minimally Invasive and Ablative Platforms Non-Invasive Platforms and Hand-Free Platforms.
- Minimally Invasive and Ablative Platforms include products such as BodyTite EmbraceRF Votiva Morpheus8 Envision IgniteRF and AccuTite which utilize bipolar radio frequency energy for subdermal fat remodeling skin tightening and tissue contraction in procedures like liposuction with simultaneous skin tightening face and body contouring and treatment of Genitourinary Syndrome of Menopause.
- Non-Invasive Platforms consist of Contoura Triton ApexRF and Solaria which deliver treatments such as simultaneous fat destruction and skin tightening permanent hair reduction through dual wavelength technology and high-power intense pulsed light for skin rejuvenation and vascular lesion treatment without requiring incisions or anesthesia.
- Hand-Free Platforms comprise EvolveX Evoke Define and Tone which use combinations of bipolar radio frequency and electrical muscle stimulation delivered through applicators mounted on belts or placed over the face or body to provide automated skin tightening fat reduction muscle stimulation and skin rejuvenation treatments without direct physician manipulation during operation.
InMode holds a leading position in the radio frequency energy-based aesthetic solutions market where it competes with companies such as AbbVie Cutera Apyx Medical Venus Concept Sisram Medical Sofwave Medical Cynosure Lumenis BTL Aesthetics and Candela Medical. Its competitive advantages stem from pioneering bipolar radio frequency technology for deep tissue penetration strong brand recognition associated with clinical leadership a broad portfolio of modular platforms extensive regulatory approvals including 37 FDA clearances and a proven track record of innovation supported by over 110 peer-reviewed publications and ongoing third-party clinical studies.
InMode serves plastic and facial surgeons aesthetic surgeons dermatologists and OB/GYNs as its primary customer base. The company also targets newer market opportunities including ENTs urologists ophthalmologists general practitioners and aesthetic clinicians through its expanding product offerings and direct sales force supported by a global network of distributors across more than 100 countries.